Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Healthtrust
Covington
Teva
Colorcon
Novartis
Chinese Patent Office
Julphar
Cerilliant
Queensland Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,783,773

« Back to Dashboard

Summary for Patent: 6,783,773
Title: Composition comprising amoxicillin and potassium clavulanate
Abstract:Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
Inventor(s): Storm; Kevin H. (Bristol, TN), Conley; Creighton P. (Bristol, TN), Roush; John A. (Kingsport, TN)
Assignee: Beecham Pharmaceuticals (Pte) Limited (Jurong, SG)
Application Number:09/971,560
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation;

Drugs Protected by US Patent 6,783,773

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Dr Reddys Labs Inc AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,783,773

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,217,430 Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan ➤ Subscribe
6,294,199 Method of treating a bacterial infection comprising administering amoxycillin ➤ Subscribe
6,660,299 Modified release pharmaceutical formulation comprising amoxycillin ➤ Subscribe
7,250,176 Method of treating a bacterial infection ➤ Subscribe
6,878,386 Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate ➤ Subscribe
6,746,692 Modified release pharmaceutical formulation comprising amoxycillin ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,783,773

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 71609 ➤ Subscribe
Taiwan I235067 ➤ Subscribe
Turkey 200102963 ➤ Subscribe
Turkey 200102962 ➤ Subscribe
Slovakia 285140 ➤ Subscribe
Slovakia 5342000 ➤ Subscribe
Slovenia 1044680 ➤ Subscribe
Slovenia 20304 ➤ Subscribe
Sweden 0001330 ➤ Subscribe
Romania 120817 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Deloitte
McKesson
Chinese Patent Office
Federal Trade Commission
QuintilesIMS
Queensland Health
Cipla
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot